文献速递关节外科

有症状良性前列腺增生:择期初次全膝关节置换术后假体周围感染的可优化风险因素

Symptomatic Benign Prostatic Hyperplasia: An Optimizable Risk Factor for Periprosthetic Joint Infection After Elective Primary Total Knee Arthroplasty.
PubMed 文献 · J Arthroplasty · 2023-05-11

该回顾性研究分析2010至2021年948例接受初次全膝关节置换或全髋关节置换的男性,按1:2匹配比较有与无有症状良性前列腺增生(sBPH)患者术后并发症。sBPH患者初次全膝关节置换后假体周围感染(PJI)发生率显著更高(4.1% vs 0.4%,P=0.029),尿路感染(UTI)和术后尿潴留(POUR)亦更常见;sBPH患者在全膝关节置换前开始抗sBPH药物治疗者PJI发生率显著低于未开始者。

要点

  • sBPH患者初次全膝关节置换后PJI发生率4.1%,显著高于无sBPH者的0.4%(P=0.029)。
  • sBPH患者全膝关节置换后UTI(P=0.029)和POUR(P<0.001)发生率均显著升高。
  • sBPH患者全髋关节置换后UTI(P=0.006)和POUR(P<0.001)发生率亦显著升高。

核心结论

  • 有症状良性前列腺增生是男性初次全膝关节置换术后假体周围感染的风险因素。
  • 术前开始适当的药物治疗可降低全膝关节置换术后假体周围感染风险及全膝关节置换和全髋关节置换术后尿路并发症风险。

研究设计与样本

  • 回顾性分析2010至2021年本院948例接受初次全膝关节置换或全髋关节置换的男性医疗数据。
  • 比较316例有sBPH患者(193髋和123膝)与632例无sBPH患者,两组按多种临床人口学变量以1:2比例匹配。
  • 亚组分析中,按sBPH患者是否在关节置换术前开始抗sBPH药物治疗进行分层。

主要发现

  • 初次全膝关节置换后PJI在sBPH患者中显著更常见(4.1% vs 0.4%,P=0.029)。
  • 全膝关节置换后UTI(P=0.029)和POUR(P<0.001)在sBPH患者中亦显著更常见。
  • 全髋关节置换后sBPH患者UTI(P=0.006)和POUR(P<0.001)发生率升高。
  • sBPH患者中,全膝关节置换前开始抗sBPH药物治疗者PJI发生率显著低于未开始者。

关键数值与推荐

  • 初次全膝关节置换后PJI发生率:sBPH患者4.1% vs 无sBPH患者0.4%(P=0.029)。
  • 全膝关节置换后UTI组间比较P=0.029,POUR组间比较P<0.001。
  • 全髋关节置换后UTI组间比较P=0.006,POUR组间比较P<0.001。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Whether symptomatic benign prostatic hyperplasia (sBPH), which is common among middle-aged and older men, affects the risk of periprosthetic joint infection (PJI) remains controversial. The present study explored this question among men undergoing total knee arthroplasty and total hip arthroplasty (TKA and THA). METHODS: We retrospectively analyzed medical data from 948 men who underwent primary TKA or THA at our institution between 2010 and 2021. We compared the incidence of postoperative complications such as PJI, urinary tract infection (UTI), and postoperative urinary retention (POUR) between 316 patients (193 hips and 123 knees) who did and 632 patients who did not have sBPH; the 2 groups of patients were matched to each other in a 1:2 ratio based on numerous clinical demographic variables. In the subgroup analyses, we stratified sBPH patients according to whether they began anti-sBPH medical therapy prior to arthroplasty. RESULTS: PJI following primary TKA was significantly more common among sBPH patients than among patients who did not have sBPH (4.1 vs 0.4%; P = .029), as were UTI (P = .029), and POUR (P < .001). Patients who had sBPH also had an increased incidence of UTI (P = .006) and POUR (P < .001) following THA. Among sBPH patients, those who started anti-sBPH medical therapy before TKA suffered significantly lower incidence of PJI than those who did not. CONCLUSION: Symptomatic benign prostatic hyperplasia is a risk factor for PJI after primary TKA among men, and starting appropriate medical therapy before surgery can reduce the risk of PJI following TKA and postoperative urinary complications following TKA and THA.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Jiang B, Xu H, Ding Z, et al. Symptomatic Benign Prostatic Hyperplasia: An Optimizable Risk Factor for Periprosthetic Joint Infection After Elective Primary Total Knee Arthroplasty. J Arthroplasty. 2023. PMID: 37172791. doi:10.1016/j.arth.2023.04.067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。